{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:10:29Z","timestamp":1781655029920,"version":"3.54.5"},"reference-count":46,"publisher":"Kurume Medical Journal","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kurume Med. J."],"published-print":{"date-parts":[[2019,6,30]]},"DOI":"10.2739\/kurumemedj.ms662002","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T22:11:02Z","timestamp":1623708662000},"page":"85-92","source":"Crossref","is-referenced-by-count":8,"title":["Diagnosis of Fetal Abnormalities during the First Trimester"],"prefix":"10.2739","volume":"66","author":[{"given":"TOSHIYUKI","family":"YOSHIZATO","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUTAKA","family":"KOZUMA","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKASHI","family":"HORINOUCHI","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKAAKI","family":"SHINAGAWA","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASATO","family":"YOKOMINE","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KIMIO","family":"USHIJIMA","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kurume University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1445","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Garret WJ, Grunwald G, and Robinson DE. Prenatal diagnosis of fetal polycystic kidney by ultrasound. Aust NZ J Obstet Gynaecol 1970; 10(1):7-9.","DOI":"10.1111\/j.1479-828X.1970.tb03298.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Campbell S, Johnstone FD, Holt EM, and May P. Anencephaly: early ultrasonic diagnosis and active management. Lancet 1972; 2(7789):1226-1227.","DOI":"10.1016\/S0140-6736(72)92273-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hori E, Koyanagi T, Yoshizato T, Maeda H, Satoh S et al. How antenatal ultrasound diagnosis of congenital malformations has contributed to fetal outcome: a 22-year review. Fetal Diagn Ther 1993; 8(6):388-401.","DOI":"10.1159\/000263857"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bronshtein M and Ornoy A. Acrania: anencephaly resulting from secondary degeneration of a closed neural tube: two cases in the same family. J Clin Ultrasound 1991; 19(4):230-234.","DOI":"10.1002\/jcu.1870190409"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Achiron R, Soriano D, Lipitz S, Mashiach S, Goldman B et al. Fetal midgut herniation into the umbilical cord: improved definition of ventral abdominal anomaly with the use of transvaginal sonography. Ultrasound Obstet Gynecol 1995; 6(4):256-260.","DOI":"10.1046\/j.1469-0705.1995.06040256.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rossi AC and Prefumo F. Accuracy of ultrasonography at 11-14 weeks of gestation for detection of fetal structural anomalies: a systemic review. Obstet Gynecol 2013; 122(6):1160-1167.","DOI":"10.1097\/AOG.0000000000000015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Karim JN, Roberts NW, Salomon LJ, and Papageorghiou AT. Systematic review of first-trimester ultrasound screening for detection of fetal structural anomalies and factors that affect screening performance. Ultrasound Obstet Gynecol 2017; 50(4):429-441.","DOI":"10.1002\/uog.17246"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Braithwaite JM, Morris RW, and Economides DL. Nuchal translucency measurements: frequency distribution and changes with gestation in a general population. Br J Obstet Gynaecol 1996; 103(12):1201-1204.","DOI":"10.1111\/j.1471-0528.1996.tb09629.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nicolaides KH, Azar G, Byrne D, Mansur C, and Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992; 304(6831):867-869.","DOI":"10.1136\/bmj.304.6831.867"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Snijders RJ, Noble P, Sebire N, Souka A, and Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352(9125):343-346.","DOI":"10.1016\/S0140-6736(97)11280-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ghi T, Huggon IC, Zosmer N, and Nocolaides KH. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001; 18(6):610-614.","DOI":"10.1046\/j.0960-7692.2001.00584.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Baer RJ, Norton ME, Shaw GM, Flessel MC, Goldman S et al. Risk of selected structural abnormalities in infants after increased nuchal translucency measurement. Am J Obstet Gynecol 2014; 211(6):675.e1-e19.","DOI":"10.1016\/j.ajog.2014.06.025"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Rayburn WF, Jolley JA, and Simpson LL. Advances in ultrasound imaging for congenital malformations during early gestation. Birth Defects Res A Clin Mol Teratol 2015; 103(4):260-268.","DOI":"10.1002\/bdra.23353"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cicero S, Rembouskos G, Vandecruys H, Hogg M, and Nicolaides KH. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan. Ultrasound Obstet Gynecol 2004; 23(3):218-223.","DOI":"10.1002\/uog.992"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ghaffari SR, Tahmasebpour AR, Jamal A, Hantoushzadeh S, Eslamian L et al. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free \u03b2-hCG and PAPP-A: a 5-year prospective study. Ultrasound Obstet Gynecol 2012; 39(5):528-534.","DOI":"10.1002\/uog.10051"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mujezinovic F and Alfrevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systemic review. Obstet Gynecol 2007; 110(3):687-694.","DOI":"10.1097\/01.AOG.0000278820.54029.e3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kim SM, Kim HH, Han YJ, Choi JS, Ryu HM et al. Change in rates of prenatal tests for chromosomal abnormality over a 12-year period in women of advanced maternal age. Obstet Gynecol Sci 2018; 61(4):453-460.","DOI":"10.5468\/ogs.2018.61.4.453"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Reichler A, Hume RF Jr, Drugan A, Bardicef M, Isada NB et al. Risk of anomalies as a function of level of elevated maternal serum alpha-fetoprotein. Am J Obstet Gynecol 1994; 171(4):1052-1055.","DOI":"10.1016\/S0002-9378(13)90033-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Merkatz IR, Nitowsky HM, Macri JN, and Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984; 148(7):886-894.","DOI":"10.1016\/0002-9378(84)90530-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cicero S, Bindra R, Rembouskos G, Spencer K, and Nicolaides KH. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003; 23(4):306-310.","DOI":"10.1002\/pd.588"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011; 31(1):7-15.","DOI":"10.1002\/pd.2637"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Cuckle H and Maymon R. Development of prenatal screening - A historical overview. Semin Perinatol 2016; 40(1):12-22.","DOI":"10.1053\/j.semperi.2015.11.003"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, and Latt SA. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA 1990; 87(9):3279-3283.","DOI":"10.1073\/pnas.87.9.3279"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Bianchi DW. Fetal cells in the maternal circulation: feasibility for prenatal diagnosis. Br J Haematol 1999; 105(3):574-583.","DOI":"10.1046\/j.1365-2141.1999.01383.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lo YMD, Corbetta N, Chambelian PF, Rai V, Sargent IL et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350(9076):485-487.","DOI":"10.1016\/S0140-6736(97)02174-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, and Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006; 169(2):400-404.","DOI":"10.2353\/ajpath.2006.060161"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Chan KC, Zhang J, Hui AB, Wong N, Lau TK et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004; 50(1):88-92.","DOI":"10.1373\/clinchem.2003.024893"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Illanes S, Denbow M, Kailasam C, Finning K, and Soothill PW. Early detection of cell-free fetal DNA in maternal plasma. Early Hum Dev 2007; 83(9):563-566.","DOI":"10.1016\/j.earlhumdev.2006.11.001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM et al. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999; 64(1):218-224.","DOI":"10.1086\/302205"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Finning KM, Martin PG, Scothill PW, and Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002; 42(8):1079-1085.","DOI":"10.1046\/j.1537-2995.2002.00165.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Devaney SA, Palomaki GE, Scott JA, and Bianchi DW. Noninvasive fetal sex determination using cell-free fetal DNA: a systemic reviews and meta-analysis. JAMA 2011; 306(6):627-636.","DOI":"10.1001\/jama.2011.1114"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Bustamante-Aragon\u00e9s A, Rodr\u00edguez de Alba M, Perlado S, Trujillo-Tiebas MJ, Arranz JP et al. Non-invasive prenatal diagnosis of single-gene disorders from maternal blood. Gene. 2012; 504(1):144-149.","DOI":"10.1016\/j.gene.2012.04.045"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Amicucci P, Gennarelli M, Novelli G, and Dallapiccola B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000; 46(2):301-302.","DOI":"10.1093\/clinchem\/46.2.301"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Vermeesch JR, Voet T, and Devriendt K. Prenatal and pre-implantation genetic diagnosis. Nat Rev Genet 2016; 17(10):643-656.","DOI":"10.1038\/nrg.2016.97"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011; 13(11):913-920.","DOI":"10.1097\/GIM.0b013e3182368a0e"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Gil MM, Accurti V, Santacruz B, Plana MN, and Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2017; 50(3):302-314.","DOI":"10.1002\/uog.17484"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Sago H, Sekizawa A and Japan NIPT consortium. Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan; 1-year experience. Prenat Diagn 2015; 35(4):331-336.","DOI":"10.1002\/pd.4539"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 370(9):799-808.","DOI":"10.1056\/NEJMoa1311037"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015; 372(17):1589-1597.","DOI":"10.1056\/NEJMoa1407349"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Choi H, Lau TK, Jiang FM, Chan MK, Zhang HY et al. Fetal aneuploidy screening by maternal plasma DNA sequencing; \u2018false positive\u2019 due to confined placental mosaicism. Prenat Diagn 2013; 33(2):198-200.","DOI":"10.1002\/pd.4024"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Bianchi DW, Parsa S, Bhatt S, Halks-Miller M, Kurtzman K et al. Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology. Obstet Gynecol 2015; 125(2):375-382.","DOI":"10.1097\/AOG.0000000000000637"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Snyder MW, Simmons LE, Kitzman JO, Coe BP, Henson JM et al. Copy-number variation and false positive prenatal aneuploidy screening results. N Engl J Med 2015; 372(17):1639-1645.","DOI":"10.1056\/NEJMoa1408408"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Bianchi DW, Chudova D, Sehnert AJ, Bhatt S, Murray K et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 2015; 314(2):162-169.","DOI":"10.1001\/jama.2015.7120"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Practice Bulletin No. 163: Screening for fetal aneuploidy. Obstet Gynecol 2016; 127(5):e123-e137.","DOI":"10.1097\/AOG.0000000000001406"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Benn P, Borrell A, Chiu RW, Cuckle H, Dugoff L et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2015; 35(8):725-734.","DOI":"10.1002\/pd.4608"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med 2016; 18(10):1056-1065.","DOI":"10.1038\/gim.2016.97"}],"container-title":["The Kurume Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/66\/2\/66_MS662002\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T04:38:43Z","timestamp":1627101523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kurumemedj\/66\/2\/66_MS662002\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,30]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2739\/kurumemedj.ms662002","relation":{},"ISSN":["0023-5679","1881-2090"],"issn-type":[{"value":"0023-5679","type":"print"},{"value":"1881-2090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,30]]},"article-number":"MS662002"}}